Industries
Functions
Displaying 1 - 10 of 63 Total Results.
Non-members: Click here to review a complimentary excerpt from “KEYTRUDA Case Study: How Merck Used Bold Indications Planning Coupled with Expansive ... (ID 5820)Companies Profiled: Merck, Advaxis, Ascentage Pharma, Astellas, more ...
$3000.00
Download Free Excerpt
Non-members: Click here to review a complimentary excerpt from “Case Study: How Horizon Therapeutics Created an Ophthalmic Blockbuster in a Rare Dise... (ID 5760)Companies Profiled: Amgen, Horizon Therapeutics
$3900.00
Non-members: Click here to review a complimentary excerpt from “Case Study: How argenx Broke Into A Captive Market To Begin Dislodging An Entrenched ... (ID 5757)Companies Profiled: argenx, Alexion Pharmaceuticals, AstraZeneca
Non-members: Click here to review a complimentary excerpt from “Skyrizi Case Study: How Compressing Cycle Time from Launch to DTC Helps Support Sales... (ID 5629)Companies Profiled: AbbVie
$900.00
Non-members: Click here to review a complimentary excerpt from “Skyrizi Case Study: Developing Early Comparative Effectiveness and Outcomes Studies t... (ID 5625)Companies Profiled: AbbVie
Non-members: Click here to review a complimentary excerpt from “COVID-19 Challenges for Product Launch Timelines and Activities (including case studi... (ID 5633)Companies Profiled: AMAG Pharmaceuticals, Almirall, Alkermes, Amicus Therapeutics, more ...
$995.00
Non-members: Click here to review a complimentary excerpt from “Growing Your Medical Device Business in Asia-Pacific & Latin America: Success Factors... (ID 5504)Companies Profiled: B.Braun, Boston Scientific, Cochlear, Fine Science Tools, more ...
$1350.00
Non-members: Click here to review a complimentary excerpt from "Tecfidera Case Study: Using Safety as a Springboard for Blockbuster Status" STUDY OVE... (ID 5360)Companies Profiled: Biogen, Sanofi, Novartis
$2000.00
Non-members: Click here to review a complimentary excerpt from "Incivek Case Study: A Well Planned and Executed Launch Makes the Most of a Small Wind... (ID 5346)Companies Profiled: Merck, Gilead Sciences, Vertex Pharmaceuticals
$1770.00
Non-members: Click here to review a complimentary excerpt from "Effexor Case Study: Using an Efficacy Message to Drive a Brand to the Top of a Crowde... (ID 5220)Companies Profiled: Wyeth
$1800.00